Daniel Koppelkamm, Cfa Email & Phone Number
@convergence-partners.ch
LinkedIn matched
Who is Daniel Koppelkamm, Cfa? Overview
A concise factual answer block for searchers comparing this professional profile.
Daniel Koppelkamm, Cfa is listed as Founder and Managing Partner at Convergence Partners AG, a with 17 employees, based in Zug, Switzerland. AeroLeads shows a work email signal at convergence-partners.ch and a matched LinkedIn profile for Daniel Koppelkamm, Cfa.
Daniel Koppelkamm, Cfa previously worked as Founder & Managing Partner at Convergence Partners Ag and Business Mentor at Tech4Eva - The Global Femtech Accelerator. Daniel Koppelkamm, Cfa holds Masters, European Business from Bayes Business School.
Email format at Convergence Partners AG
This section adds company-level context without repeating Daniel Koppelkamm, Cfa's masked contact details.
AeroLeads found 1 current-domain work email signal for Daniel Koppelkamm, Cfa. Compare company email patterns before reaching out.
About Daniel Koppelkamm, Cfa
Active investor in young technology companies that have a positive impact on planet and society. Founder of Convergence Partners, a HealthTech venture capital firm focused on healthcare sectors with large unmet needs, such as Brain and Womens Health. Previously, co-initiator of one of Europe`s first dedicated CleanTech funds. Global citizen who is passionate about linking cultures for success. Currently, we have a particular interest in mental & neurological health, technodelics-, longevity-and womens health-related technologies and business models. I am also excited by the disruption that blockchain technology and computational biology are bringing to healthcare.
Listed skills include Private Equity, Venture Capital, Alternative Investments, Hedge Funds, and 20 others.
Daniel Koppelkamm, Cfa's current company
Company context helps verify the profile and gives searchers a useful next step.
Daniel Koppelkamm, Cfa work experience
A career timeline built from the work history available for this profile.
Founder & Managing Partner
CurrentConvergence Partners is a pan-European venture capital firm focused on investments in Mental & Brain Health, Womens Health and AI-driven drug discovery. Convergence acts as an active sparring partner to founders, supporting their international scale-up in the worlds largest healthcare markets. Convergence is currently raising a EUR 100m Brain Health Fund.
Business Mentor
Current
Co-Founder & Council Member
CurrentACF’s mission is to protect LIFE by amplifying & safeguarding ancient indigenous wisdom and cultures for the elevation of human consciousness.
Co-Founder & Director
CurrentCHL manages all start-up cross-border acceleration activities of Convergence Partners.
Investor
CurrentCopresence is an AI and software platform that offers a digital avatar solution for the connected world.
Investor
CurrentClerkenwell Health is a leading psychedelic specialty CRO offering specialist trial design, regulatory submission and trial delivery services.
Investor
CurrentInterAx has commercialised a drug discovery and optimisation technology platform to go beyond target identification and ligand discovery. It is connecting AI and cell signalling to design drugs triggering a precisely defined cell pathway modulation. InterAx is also developing own drug assets in neurology and womens health.
Investor & Advisor
CurrentSensit! is a fast growing haptics technology leader in converting sound into touch - "awakening" the digital world. Application areas include Mental Health therapy, Gaming, Virtual Reality and the Metaverse.
Investor
Currentb-rayZ is a medical AI company that supports the daily work of the radiologist in mammography with a real-time assessment of image quality and breast density.
Investor
Currentneotiv develops unique cognitive tests – embedded in a digital platform – to enable early medical assessment and follow-up of memory problems in the context of Alzheimer's disease.
Investor
CurrentneuroCare is active in the fast growing market for neurotherapy, a non-invasive option for mental health, pain and rehabilitation using neuromodulation technologies integrated with psychotherapy.
Investor
CurrentOxford Endovascular is a spin out from Oxford University developing technology to prevent brain haemorrhage. OxiFlow™️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture.
Investor
CurrentGedea Biotech is a medical nutrition company focused on developing an antibiotic-free, safe and effective treatment of vaginal fungal infections.
Investor
CurrentSOM Biotech is a medical AI company focused on the accelerated discovery and development of therapies for neuro-degenerative orphan diseases through a proprietary AI-based drug discovery technology.
Director, Board Member
Cleantech co-investment vehicle with a leading Spanish family office.
Principal, General Partner & Investment Committee Member
Hightech venture capital firm focused on early growth-stage companies in the D-A-CH region.
Colleagues at Convergence Partners AG
Other employees you can reach at convergence-partners.ch. View company contacts for 17 employees →
Daniel Koppelkamm, Cfa education
Masters, European Business
Cfa, Chartered Financial Analyst
Caia, Chartered Alternative Investment Analyst
Bsc, Business Studies
Frequently asked questions about Daniel Koppelkamm, Cfa
Quick answers generated from the profile data available on this page.
What company does Daniel Koppelkamm, Cfa work for?
Daniel Koppelkamm, Cfa works for Convergence Partners AG.
What is Daniel Koppelkamm, Cfa's role at Convergence Partners AG?
Daniel Koppelkamm, Cfa is listed as Founder and Managing Partner at Convergence Partners AG.
What is Daniel Koppelkamm, Cfa's email address?
AeroLeads has found 1 work email signal at @convergence-partners.ch for Daniel Koppelkamm, Cfa at Convergence Partners AG.
Where is Daniel Koppelkamm, Cfa based?
Daniel Koppelkamm, Cfa is based in Zug, Switzerland while working with Convergence Partners AG.
What companies has Daniel Koppelkamm, Cfa worked for?
Daniel Koppelkamm, Cfa has worked for Convergence Partners Ag, Tech4Eva - The Global Femtech Accelerator, Aguilacondor Foundation, Convergence Holding Limited, and Copresence.
Who are Daniel Koppelkamm, Cfa's colleagues at Convergence Partners AG?
Daniel Koppelkamm, Cfa's colleagues at Convergence Partners AG include Jenny Hao, Nicolas L. Kiep, and Michelle (Xingyue) Chen.
How can I contact Daniel Koppelkamm, Cfa?
You can use AeroLeads to view verified contact signals for Daniel Koppelkamm, Cfa at Convergence Partners AG, including work email, phone, and LinkedIn data when available.
What schools did Daniel Koppelkamm, Cfa attend?
Daniel Koppelkamm, Cfa holds Masters, European Business from Bayes Business School.
What skills is Daniel Koppelkamm, Cfa known for?
Daniel Koppelkamm, Cfa is listed with skills including Private Equity, Venture Capital, Alternative Investments, Hedge Funds, Investments, Equity Research, Funding, and Corporate Finance.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial